Clinical Trials Directory

Trials / Conditions / Renal Medullary Carcinoma

Renal Medullary Carcinoma

8 registered clinical trials studyying Renal Medullary Carcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingPembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma
NCT06302569
Giuseppe ProcopioPhase 2
RecruitingSacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as
NCT06161532
National Cancer Institute (NCI)Phase 2
Active Not RecruitingPhase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla
NCT05347212
M.D. Anderson Cancer CenterPhase 2
CompletedEffects of Itraconazole and Rifampin on the Blood Tazemetostat Levels
NCT04537715
Epizyme, Inc.Phase 1
CompletedA Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated
NCT02875548
Epizyme, Inc.Phase 1 / Phase 2
CompletedA Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma
NCT02601950
Epizyme, Inc.Phase 2
CompletedTotal-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Tr
NCT00027820
Fred Hutchinson Cancer CenterPhase 1 / Phase 2
No Longer AvailableTazemetostat Expanded Access Program for Adults With Solid Tumors
NCT03874455
Epizyme, Inc.—